CVS Health Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five increased by 3.5% to $11.37B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.6%, from $10.47B to $11.37B.
other_available_for_sale_securities_debt_maturities_afte_2b276a| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.17B | $6.81B | $6.70B | $6.82B | $7.32B | $7.41B | $8.03B | $8.97B | $10.47B | $10.67B | $10.98B | $11.37B |
| QoQ Change | — | -5.0% | -1.5% | +1.8% | +7.3% | +1.3% | +8.4% | +11.7% | +16.7% | +1.9% | +3.0% | +3.5% |
| YoY Change | — | — | — | -4.8% | +7.5% | +10.6% | +17.7% | +22.6% | +41.2% | +32.8% | +22.4% | +8.6% |